Regulatory Top Stories SurGenTec® Breaks New Ground with FDA Clearance for OsteoFlo® HydroFiber™, Receives Indication for Stand-Alone Use Equivalent to Autograft byJosh SandbergJanuary 16, 2025
Biologics Regulatory Top Stories Ventris Medical Receives 510(k) Clearance for Innovative Backpack® Bone Graft Containment System byJosh SandbergJanuary 9, 2025
Biologics Spine Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use byJosh SandbergSeptember 24, 2024
Biologics Top Stories Biogennix Announces Publication of a Scientific Study on Its Advanced Bone Graft Technology byTim AllenJune 12, 2024
Biologics Regulatory Spine Top Stories Ventris Medical Receives 510(k) Additional Clearance for Amplify® Standalone Bone Graft Putty byJosh SandbergMarch 13, 2024
Regulatory Spine Top Stories SurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone Graft byJosh SandbergMarch 7, 2024
Biologics Spine Top Stories Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion byJosh SandbergJanuary 4, 2024
Biologics Spine Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia byJosh SandbergApril 11, 2023
